Literature DB >> 2962540

Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.

R Bucknall1, M Leirisalo-Repo, O Laitinen, J V Jones.   

Abstract

Antibody production in response to the primary immunogen bacteriophage phi X174 was investigated in 14 patients with previous yersinia arthritis (YA) and in 15 controls. HLA-B27 occurred in 10 patients with YA and in three controls. After primary and secondary immunisation the antibody responses were essentially similar both in patients with YA and controls. Consequently our results suggest that antibody response to a foreign antigen does not differ between patients with YA and a normal control population. In addition, there was no difference in peak antibody responses between individuals with HLA-B27 and those without HLA-B27.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2962540      PMCID: PMC1003417          DOI: 10.1136/ard.46.12.883

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  Diminished mixed lymphocyte response in ankylosing spondylitis.

Authors:  S L Wee; T J Daymond
Journal:  Tissue Antigens       Date:  1978-05

2.  Diminished mixed lymphocyte reaction in ankylosing spondylitis, relatives, and normal individuals all with HL-A 27.

Authors:  B Nikbin; D A Brewerton; D C James; J R Hobbs
Journal:  Ann Rheum Dis       Date:  1976-02       Impact factor: 19.103

3.  Relation between HLA-B27 and clinical features in patients with yersinia arthritis.

Authors:  O Laitinen; M Leirisalo; G Skylv
Journal:  Arthritis Rheum       Date:  1977-06

4.  DTT test: a new method to differentiate IgM and IgG erythrocyte antibodies.

Authors:  B Pirofsky; E R Rosner
Journal:  Vox Sang       Date:  1974       Impact factor: 2.144

5.  The immune response to thetaX 174 in man. I. Primary and secondary antibody production in normal adults.

Authors:  D B Peacock; J V Jones; M Gough
Journal:  Clin Exp Immunol       Date:  1973-04       Impact factor: 4.330

6.  Lymphocyte abnormalities in ankylosing spondylitis.

Authors:  P T Fan; P J Clements; D T Yu; G Opelz; R Bluestone
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

7.  Influence of tubercle aggregate size on severity of adjuvant arthritis in the rat.

Authors:  S P Liyanage; H L Currey; B Vernon-Roberts
Journal:  Ann Rheum Dis       Date:  1975-02       Impact factor: 19.103

8.  Immune function in ankylosing spondylitis: apparent relationship between streptococcal responses and HLA B27.

Authors:  P J Zilko; M Thevathasan; R L Dawkins
Journal:  J Rheumatol Suppl       Date:  1977

9.  Antibody responses in arthritic and uncomplicated Yersinia enterocolitica infections.

Authors:  P S Mattila; V Valtonen; M R Tuori; O Mäkelä
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

10.  HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis.

Authors:  M Leirisalo; O Laitinen; A Tiilikainen
Journal:  J Rheumatol Suppl       Date:  1977
View more
  3 in total

Review 1.  Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors:  R Tertti; P Toivanen
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

2.  Antibody producing capacity to the bacteriophage phi X174 in rheumatoid arthritis.

Authors:  R Bucknall; P Bacon; C Elson; J V Jones
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

3.  Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus.

Authors:  Michał Zimecki; Jolanta Artym; Maja Kocieba; Beata Weber-Dabrowska; Jan Borysowski; Andrzej Górski
Journal:  BMC Microbiol       Date:  2009-08-17       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.